Integrated Regional Information Networks - December 16, 2005
JOHANNESBURG, 16 December (PLUSNEWS) - A decision by the World Trade Organisation (WTO) to amend a Trade Related Aspects of Intellectual Property Rights (TRIPS) agreement, drew criticism from AIDS activists on Friday.
According to the Global Network of People living with HIV/AIDS (GNP+), by making permanent the waiver adopted in August 2003, WTO members had ignored the reality and difficulties in accessing drugs and treatment on the ground.
GNP+ said the decision was a "bad deal", which would block access to affordable medicines for countries with little or no production capacity, and could only serve to cripple an effective response to public health issues, especially HIV/AIDS.
"How can a system that requires order-by-order, drug-by-drug, country-by-country procedures be seen as an improvement?" said GNP+ director Mauro Guarinieri in a statement.
People and Planet, a UK-based rights group, also denounced the amendment, saying that WTO had once again demonstrated its priorities lied with the interests of rich countries and large pharmaceutical companies at the expense of millions of people living in developing countries.
051216
IR051245
Copyright © 2005 - Integrated Regional Information Networks (IRIN). Reproduction of this article (other than one copy for personal reference) must be cleared through the Integrated Regional Information Network. .
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2005. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980 – 2005. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .